Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| content:opsoclonus_myoclonus_ataxia_syndrome [2024/03/12 08:58] – biju.hameed@gmail.com | content:opsoclonus_myoclonus_ataxia_syndrome [2024/03/15 19:11] (current) – biju.hameed@gmail.com | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | ====== Opsoclonus Myoclonus Ataxia Syndrome ====== | ||
| + | {{page> | ||
| ^ Recommendations for the Dosing and Monitoring of Immunotherapeutic Agents in the Treatment of OMAS: Steroid Treatment and Ivig || | ^ Recommendations for the Dosing and Monitoring of Immunotherapeutic Agents in the Treatment of OMAS: Steroid Treatment and Ivig || | ||
| | **Treatment of OMS in children** | | **Treatment of OMS in children** | ||